Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Mar;105(5):R1-8.
doi: 10.1172/JCI8647.

Factors influencing T-cell turnover in HIV-1-seropositive patients

J M McCune  1 , M B Hanley, D Cesar, R Halvorsen, R Hoh, D Schmidt, E Wieder, S Deeks, S Siler, R Neese, M Hellerstein
Affiliations

Factors influencing T-cell turnover in HIV-1-seropositive patients

J M McCune et al. J Clin Invest. 2000 Mar.

Abstract

HIV-1 disease is associated with pathological effects on T-cell production, destruction, and distribution. Using the deuterated (2H) glucose method for endogenous labeling, we have analyzed host factors that influence T-cell turnover in HIV-1-uninfected and -infected humans. In untreated HIV-1 disease, the average half life of circulating T cells was diminished without compensatory increases in cell production. Within 12 weeks of the initiation of highly active antiretroviral therapy (HAART), the absolute production rates of circulating T cells increased, and normal half-lives and production rates were restored by 12-36 months. Interpatient heterogeneity in the absolute degree of turnover correlated with the relative proportion of naive- and memory/effector-phenotype T cells in each of the CD4+ and CD8+ populations. The half-lives of naive-phenotype T cells ranged from 116-365 days (fractional replacement rates of 0.19-0.60% per day), whereas memory/effector-phenotype T cells persisted with half-lives from 22-79 days (fractional replacement rates of 0.87-3.14% per day). Naive-phenotype T cells were more abundant, and the half-life of total T cells was prolonged in individuals with abundant thymic tissue, as assessed by computed tomography. Such interpatient variation in T-cell kinetics may be reflective of differences in functional immune reconstitution after treatment for HIV-1 disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
k and absolute production rates of CD4+ and CD8+ T cells in HIV-1–seronegative and HIV-1–seropositive subjects who were either untreated or treated with HAART. Values of k (per day) and of absolute production rates (cells/μL per day) for peripheral blood CD4+ and CD8+ T cells are shown for different groups of subjects, including HIV-1–seronegative subjects (HIV–) and HIV-1–seropositive subjects who were either untreated (HIV+) or treated with HAART for 12 weeks (ST) or for 12–36 months (LT). Some of the data points shown in this figure are from subjects previously described in ref. (see Table 1 for details).
Figure 2
Figure 2
Relationship between k, percent naive CD4+ T cells, and thymic index. (a) Correlations between k of total CD4+ T cells, percent naive CD4+ T cells, and thymic index are derived from the data presented in Table 1. (b) Pairwise correlations in the short-term HAART group between k of CD4+ T cells and thymic index (top) and between k and percent naive-phenotype CD4+ T cells (bottom).
Figure 3
Figure 3
Biphasic kinetics of memory/effector-phenotype CD4+ and CD8+ T cells. Incorporation/decay kinetics for memory/effector- and naive-phenotype T cells. Results from a healthy, HIV-1–seronegative control subject are shown (as enrichment of dA isolated from the DNA of sorted subpopulations) with [2H]glucose labeling over a 4-day period (arrow) and blood sampling on days 4, 10, 18, 30, and 40. Subpopulations isolated: M/E, memory/effector; N, naive; T, total. Left: CD4+ T cells. Right: CD8+ T cells.
Figure 4
Figure 4
Prospective analysis of k as a function of time after initiation of HAART. Values for k (per day) for peripheral blood CD4+ (dotted lines) and CD8+ T cells (solid lines) for 2 HIV-1–seropositive subjects treated for 3 or for 18 months with HAART. Table 1 provides more complete data for subject 1 (see group III, no. 1 and group IV, no. 7) and subject 2 (see group III, no. 3 and group IV, no. 8).
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ho DD, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373:123–126. - PubMed
    1. Wei X, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117–122. - PubMed
    1. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science. 1998;279:1223–1227. - PubMed
    1. Rosenzweig M, et al. Increased rates of CD4+ and CD8+ T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci USA. 1998;95:6388–6393. - PMC - PubMed
    1. Tenner-Racz K, et al. The unenlarged lymph nodes of HIV-1-infected asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med. 1998;187:949–959. - PMC - PubMed

Publication types